In monocyte/macrophage‐derived osteoclasts, DPP‐4/CD26 expression is progressively upregulated under certain pathological conditions, such as osteolytic bone lesions from multiple myeloma, osteosarcoma, adenocarcinoma (Nishida et al. 2014). Here, DPP4 is linked to osteosarcoma.